Traded Apr 1 · filed 2 days later
Gift or transfer — classified separately from trades.
Loading…
Traded Mar 3, 2026 · Filed Mar 4, 2026
A United Therapeutics director sold $25K of United Therapeutics shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$25,460
Shares × reported transaction price
6 days after results of Feb 25, 2026, 64 days before results of May 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +11.1% | −1.3% | +12.4% |
| 30 days | +14.2% | −3.8% | +18.0% |
| 90 days | +10.2% | +10.9% | −0.7% |
| 180 days | +4.1% | +12.0% | −7.8% |
Past results only. Not a forecast.
Traded Apr 1 · filed 2 days later
Gift or transfer — classified separately from trades.
Traded Apr 1 · filed 2 days later
Gift or transfer — classified separately from trades.
Traded Apr 2 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.